NewAmsterdam Pharma pany N.V.(NAMS) - 2025 FY - Earnings Call Transcript
NewAmsterdam Pharma Company (NasdaqGM:NAMS) FY 2025 Conference December 03, 2025 03:15 PM ET Speaker0Yeah, the Global Healthcare Conference at Citi. My name's Jeff Meacham. I am the head of healthcare, global head of biotech, pharma research. Fun, fun. We're thrilled today to have NewAmsterdam Pharma. So we have Michael Davidson, CEO. We have Ian Somaiya, CFO. Guys, thanks a lot for the time.Speaker1Thanks, Jia.Speaker0So maybe we'll just do a quick background, Michael. You want to give a couple-minute pitc ...